| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 43.1836 | 18 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.5075 | 34 |
| GSM780709 | Untreated after 4 days (C3_1) | 43.6905 | 21 |
| GSM780719 | Untreated after 4 days (C1_2) | 46.006 | 32 |
| GSM780720 | Untreated after 4 days (C2_2) | 40.2506 | 7 |
| GSM780721 | Untreated after 4 days (C3_2) | 45.7095 | 31 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 41.5103 | 11 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.9736 | 37 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.3589 | 29 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 45.7416 | 31 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 46.8286 | 36 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 44.9976 | 27 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 43.3555 | 19 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 47.4067 | 39 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 48.0224 | 41 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 46.214 | 33 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 47.1867 | 38 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 44.1138 | 23 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 43.3128 | 19 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 55.2749 | 60 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 42.6351 | 16 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 46.3289 | 34 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 39.6266 | 5 |